Evaluation of Hippo Pathway and CD133 in Radiation Resistance in Small-Cell Lung Cancer

Table 1

The expression of MST2, pMST2, pYAP1, and their relationships with the clinicopathological characteristics in SCLC patients.

Variables	Total number n = 37	MST2 expression			pMST2 expression			pYAP1 expression
		Low	High		Low	High		Low	High
		22	15		23	14		29	8
Age				0.385			0.420			0.931
≤56	18	12	6		10	8		14	4
>56	19	10	9		13	6		15	4
Gender				0.683			0.595			0.862
Male	33	20	13		21	12		26	7
Female	4	2	2		2	2		3	1
Stage				0.476			0.869			0.098
LD	27	17	10		17	10		23	4
ED	10	5	2		6	4		6	4